MedTrace Logo

The First Puncture Success Rate of a Novel Injeq IQ-Tip™ System in Pediatric Lumbar Punctures

NCT04070144 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-06-13

Study results available
· View outcomes & findings →

Summary

The investigation aims to demonstrate the first puncture success rate, as proxy of clinical benefit and clinical performance, of bioimpedance spectroscopy based spinal needle guidance method among pediatric hemato-oncology patients requiring lumbar punctures.

Conditions

  • Lumbar Puncture

Interventions

DEVICE

IQ-Tip(tm) system

Physician performs therapeutic or diagnostic lumbar puncture using Injeq IQ-Tip(tm) system

Sponsors & Collaborators

  • Injeq Ltd

    lead INDUSTRY

Principal Investigators

  • Sauli Palmu, PhD MD · Tampere University Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-08
Primary Completion
2020-08-06
Completion
2020-10-02

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04070144 on ClinicalTrials.gov